J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Gen Virol 85 (2004), 609-613; DOI 10.1099/vir.0.19760-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fowler, P.
Right arrow Articles by Efstathiou, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fowler, P.
Right arrow Articles by Efstathiou, S.
Agricola
Right arrow Articles by Fowler, P.
Right arrow Articles by Efstathiou, S.
© 2004 Society for General Microbiology

Short Communication

Vaccine potential of a murine gammaherpesvirus-68 mutant deficient for ORF73

Polly Fowler and Stacey Efstathiou

Division of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK

Correspondence
Stacey Efstathiou
se{at}mole.bio.cam.ac.uk

A murine gammaherpesvirus (MHV-68) containing a deletion of the putative plasmid maintenance protein ORF73 exhibits a severe latency deficit. In this study the ability of an ORF73 deletion mutant ({Delta}73) to confer in vivo protection against subsequent challenge with wild-type virus has been examined. Vaccination studies have shown that {Delta}73 vaccination reduced latent infection of wild-type challenge virus to a level below the limit of detection. These results indicate that a live-attenuated gammaherpesvirus that cannot persist is an effective vaccine.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
B. Kayhan, E. J. Yager, K. Lanzer, T. Cookenham, Q. Jia, T.-T. Wu, D. L. Woodland, R. Sun, and M. A. Blackman
A Replication-Deficient Murine {gamma}-Herpesvirus Blocked in Late Viral Gene Expression Can Establish Latency and Elicit Protective Cellular Immunity
J. Immunol., December 15, 2007; 179(12): 8392 - 8402.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
L. Gillet, V. Daix, G. Donofrio, M. Wagner, U. H. Koszinowski, B. China, M. Ackermann, N. Markine-Goriaynoff, and A. Vanderplasschen
Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning
J. Gen. Virol., April 1, 2005; 86(4): 907 - 917.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. J. Obar, D. C. Donovan, S. G. Crist, O. Silvia, J. P. Stewart, and E. J. Usherwood
T-Cell Responses to the M3 Immune Evasion Protein of Murid Gammaherpesvirus 68 Are Partially Protective and Induced with Lytic Antigen Kinetics
J. Virol., October 1, 2004; 78(19): 10829 - 10832.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2004 by the Society for General Microbiology.